loader
Accretion Pharmaceuticals Limited SME IPO
Issue Size (Net)
up to Rs.29.75 Cr
Price Band
Rs.96 to Rs.101 per share
Issue Opens
May 14, 2025
Issue Closes
May 16, 2025

Company Highlights

1.Company Information

Incorporated in 2012, Accretion Pharmaceuticals Limited is a pharmaceutical company that manufactures and sells tablets, capsules, and other healthcare products. The company also offers contract manufacturing services. The Company manufactures and markets Tablets, Capsules, Oral Liquids, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), and Oral Powder (Sachet, Dry Syrup). The company also holds ISO 9001:2015, ISO 14001:2015, and ISO 22000:2005 certifications, reflecting its dedication to quality and environmental management systems. The company's manufacturing unit is located in Ahmedabad, Sanand, Gujarat. The company has expanded its global footprint, marking its presence in more than 20 countries, including regions in Africa, Southeast Asia, and the Middle East.
Product Portfolio and Services
Tablets and Capsules – Covering antibiotics, anti-inflammatory, pain management, cardiovascular, and gastrointestinal medicines.
Oral Liquids and Syrups – Used for respiratory, pediatric, and digestive treatments.
External Preparations – Including medicated lotions, gels, ointments, and dusting powders for skin care and dermatological treatments.
Ayurvedic and Herbal Products – Focused on natural wellness solutions for immunity, digestion, and general health.
As of January 2025, the company has 83 employees (including 4 Executive Directors) on its payroll.

2. Objects of the Issue

1 Capital expenditure towards purchase of new equipment/ machineries, etc.
2 Capital expenditure towards upgradation of existing manufacturing facility.
3 Repayment/prepayme nt of certain borrowings availed by the Company
4 Funding working capital requirements
5 General Corporate Purpose"

3.Accretion Pharmaceuticals IPO Registrar
Kfin Technologies Limited

Phone: 04067162222, 04079611000
Email:  apl.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/

Accretion Pharmaceuticals Limited Financial Information IPO Financials

Period Ended
Total Assets
Total Revenue
Profit After Tax
Net Worth
Reserves and Surplus
Total Borrowing
31-Dec-24
39.99
35.75
5.24
13.58
5.41
13.79
31-Mar-24
27.05
33.94
3.88
5.35
1.35
13.48
31-Mar-23
20.58
29.53
0.1
3.84
0
8.47
31-Mar-22
17.74
22.58
0.08
3.08
0
7.61
Amount in Rs. Crore

Accretion Pharmaceuticals IPO Details

Issue Opening Date
May 14, 2025
Issue Closing Date
May 16, 2025
Face Value
Rs.10 per share
Price
Rs.96 to Rs.101 per share
Lot Size
1200 Shares
Issue Size
29,46,000 shares (aggregating up to Rs.29.75 Cr)
Fresh Issue
29,46,000 shares (aggregating up to Rs.29.75 Cr)
Issue Type
Bookbuilding IPO
Listing At
NSE SME

Accretion Pharmaceuticals Limited IPO Timeline

Event
Tentative Date
Opening Date
Wed, May 14, 2025
Closing Date
Fri, May 16, 2025
Basis of Allotment
Mon, May 19, 2025
Initiation of Refunds
Tue, May 20, 2025
Credit of Shares to Demat
Tue, May 20, 2025
Listing Date
Wed, May 21, 2025
Cut-off time for UPI mandate confirmation
5 PM on May 16, 2025

Prospectus

Prospectus File

RR Investors Capital Services Pvt. Ltd AMFI-registered Mutual Fund Distributor

ARN-0032 Validity 14-Mar-2027

Head Office - 4th floor, Indraprakash Building 21, Barakhamba Road, New Delhi – 110001

callLandline Number
+91 11-4444-1111

Customer Care
+91 9350316010

Security
  • SSL
Follow Us

SEBI Registration No: NSE Cash: INB231219636 | SEBI Registration No: NSE Derivative: INF231219636 | SEBI Registration No: BSE Cash: INB011219632 | SEBI Registration No: MCX-SX: INE261219636 | SEBI Registration No: NSE Currency: INE231219636 | SEBI Registration No: USE: INE271219631 | SEBI Registration No: CDSL: IN-DP-CDSL-3242005 | NCDEX Membership No: 00635 | MCX Membership No: 28850 | NSEL Membership No: 10650 | RBI Registration No: NBFC: N-14.03215 | IRDA Registration Number : CB-066/03 | AMFI Registration No : ARN -0032| SEBI Registration No: Merchant Banker: INM000007508


* Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing.


© 2022 RR Investors Capital Services Pvt. Ltd | All Rights Reserved.